This early-phase trial is testing whether adding the targeted drug zanubrutinib to a standard chemotherapy cocktail (R-PolaCHP) is safe and effective for people with newly diagnosed diffuse large B-cell lymphoma. The study aims to find the best dose and watch for side effects. Ab…
Phase: PHASE1 • Sponsor: Yazeed Sawalha • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC